AMAT vs STRO · P/E 56, rev $28.37B vs rev $62.0M
Applied Materials Inc (AMAT) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported AMAT revenue for 2025-10-26 was $28.37B. Net income was $7.00B. Revenue was up 4.4% from 2024-10-27 to 2025-10-26. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. STRO currently screens at market cap $470.8M.
Not investment advice. Open the AMAT and STRO stock pages for the full models.
Not investment advice.